GGrantIndex
← Leaderboards

Gal Shafirstein

Univ Of Arkansas For Med Scis

$8,387,565
Attributed
$11,999,341
Total exposure
10
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200625
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,999,341 · 10

By mechanism

R01$4,580,605 · 3
R44$4,018,105 · 2
R42$2,000,000 · 1
R21$724,589 · 2
R41$399,917 · 1
R43$276,125 · 1

Top collaborators

Others in their field

Top investigators on “Tumor

Research focus

TumorLightDosePuva PhotochemotherapyLasersInterstitialTreatment PlanningMalignant NeoplasmsBaseResponseClinical ResearchOxygenMonitorDiffuseFutureDosimetryPorfimer SodiumTissuesOryctolagus CuniculusEffective TherapyImage GuidedAnimalsLocally Advanced Malignant NeoplasmSuccess

Grant awards (24)

Interstitial Chemophototherapy as an Intervention in Locally Advanced Pancreatic Cancer$677,176
R01 · FY2025 · CA
Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction$675,462
R01 · FY2025 · CA · contact PI
Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction$76,836
R01 · FY2025 · CA · contact PI
Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction$698,487
R01 · FY2024 · CA · contact PI
Interstitial Chemophototherapy with Light-Activated Nanoparticulate Doxorubicin$998,596
R42 · FY2023 · CA · contact PI
Interstitial Chemophototherapy with Light-Activated Nanoparticulate Doxorubicin$1,001,404
R42 · FY2022 · CA · contact PI
Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa$1,000,000
R44 · FY2022 · CA
Optical Surface Applicator Light Dosimetry for Ruthenium-based Photosensitizer Mediated Intraoperative Photodynamic Therapy$181,860
R21 · FY2022 · CA · contact PI
Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa$1,050,000
R44 · FY2021 · CA
Optical Surface Applicator Light Dosimetry for Ruthenium-based Photosensitizer Mediated Intraoperative Photodynamic Therapy$240,100
R21 · FY2021 · CA · contact PI
Integrated Image-Guided Dosimetry and Treatment Planning for Photodynamic Therapy$513,789
R01 · FY2020 · CA · contact PI
Interstitial Chemophototherapy with Light-Activated Nanoparticulate Doxorubicin$399,917
R41 · FY2020 · CA · contact PI
Interstitial Intensity Modulated Photodynamic Therapy Phase II$2,500
R44 · FY2020 · CA
Interstitial Intensity Modulated Photodynamic Therapy Phase II$980,701
R44 · FY2019 · CA
Integrated Image-Guided Dosimetry and Treatment Planning for Photodynamic Therapy$443,212
R01 · FY2019 · CA · contact PI
Integrated Image-guided Dosimetry & Treatment Planning PDT$28,988
R01 · FY2019 · CA · contact PI
Interstitial Intensity Modulated Photodynamic Therapy Phase II$984,904
R44 · FY2018 · CA
Integrated Image-Guided Dosimetry and Treatment Planning for Photodynamic Therapy$479,218
R01 · FY2018 · CA · contact PI
Interstitial Intensity Modulated Photodynamic Therapy (i-IMPDT)$50,000
R43 · FY2018 · CA
Integrated Image-Guided Dosimetry and Treatment Planning for Photodynamic Therapy$489,763
R01 · FY2017 · CA · contact PI
Interstitial Intensity Modulated Photodynamic Therapy (i-IMPDT)$226,125
R43 · FY2017 · CA
Integrated Image-Guided Dosimetry and Treatment Planning for Photodynamic Therapy$497,674
R01 · FY2016 · CA · contact PI
Breast Tissue ablation by Conductive Heating$135,274
R21 · FY2007 · CA · contact PI
Breast Tissue ablation by Conductive Heating$167,355
R21 · FY2006 · CA · contact PI